Page last updated: 2024-10-15

glucagon, n(alpha)-trinitrophenyl-his(1)-homo-arg(12)-

Description

glucagon, N(alpha)-trinitrophenyl-His(1)-homo-Arg(12)-: potent antagonist of glucagon-stimulated adenylate cyclase system; lowers blood sugar [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID126843425
MeSH IDM0105008

Synonyms (7)

Synonym
th glucagon
glucagon, n(alpha)-trinitrophenyl-his(1)-homo-arg(12)-
glucagon, n-(2,4,6-trinitrophenyl)-12-(n6-(aminoiminomethyl)-l-lysine)-
1-n(alpha)-trinitrophenyl-his-12-homo-arg-glucagon
glucagon thg
glucagon, n(alpha)-trinitrophenylhistidyl(1)-homoarginine(12)-
75881-61-7

Dosage Studied

ExcerptReference
"Phorbol myristate acetate (PMA) inhibits glucagon-stimulated cyclic AMP accumulation and shifts to the right the dose-response curve to glucagon for ureagenesis."( Modulation of glucagon actions by phorbol myristate acetate in isolated hepatocytes. Effect of hypothyroidism.
García-Sáinz, JA; Hernández-Sotomayor, SM; Hruby, VJ; Macías-Silva, M; Torres-Márquez, ME; Trivedi, D, 1990
)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (88.89)18.7374
1990's1 (11.11)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]